** Medical device maker ResMed's RMD.N shares rise 8.1% to $231.81
** RMD posted late on Wednesday Q1 adj. profit of $2.37 per share, beating analysts' estimates of $2.36 per share, according to data compiled by LSEG
** Company's Q1 revenue rose 8% to $1.29 billion
** ResMed said it is "very well positioned" and does not expect the introduction of U.S. tariffs to have a material impact on its financial results
** Brokerage William Blair says ResMed products are also exempt from the announced April tariffs, making it "one of the safer stories, if not the safest, from recent headlines"
** "We are decreasing our forward EPS estimates modestly, given a challenging macro environment" - Jefferies
** As of last close, RMD has risen 1.3% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.